Midi Health expands women's care access in all 50 states

30 Oct 2023
www.mobihealthnews.com
Midi Health expands women's care access in all 50 states
Preview
Source: mobihealthnews
Photo: Recep Buyukguzel/Getty Images
Midi Health, a virtual care clinic for women 40 years and above, announced it is expanding its offering to employers in all 50 states beginning in January 2024.
The announcement comes just weeks after the company relayed it closed a $25 million Series A funding round led by GV (Google Ventures), bringing the company's total raise to $40 million.
Earlier this month, the company also announced a partnership with Houston-based Memorial Hermann Health System to expand care access to perimenopausal and menopausal women.
Midi offers telehealth services guided by a network of nurse practitioners overseen by physicians and researchers, all covered by insurance. Midi bills ​​insurers for visits with no additional charges to employers. The company also provides interventions from lifestyle coaching to prescription medication.
THE LARGER TREND
In 2022, Midi Health raised $14 million in seed funding. At the time, the company provided care in California and said it would use the funds to expand nationwide and launch partnerships.
Earlier this year, the women's care company announced a partnership with Lifepoint Health, a national healthcare delivery network, to improve access to care for women as they age.
In August, benefits management company Progyny announced its employer clients in all 50 states would be able to offer perimenopause and menopause care to employees thanks to partnerships with Midi Health and digital menopause care delivery platform Gennev.
Other companies offering virtual care services to menopausal women are telehealth startup Evernow and virtual menopause care company Upliv.
Tags: Midi Health, women's health, women's care, employer benefit
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
-
Targets
-
Drugs
-
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.